LRFN4 and adrenal cortex carcinoma: DFS analysis (Figure 6B) showed correlation with worse outcomes for high LRFN4 expression in ACC (P = 1.5e-05), PRAD (P = 0.00024), SARC (P = 0.0032), and UVM (P = 0.00012), while low LRFN4 expression was associated with poor DFS in OV (P = 0.004) (34).